Rising Prevalence of Memory-Related Disorders and New Drug Approvals by FDA Drives the Cognitive and Memory Enhancer Drugs Market.

The global cognitive and memory enhancer drugs market is expected to grow at a CAGR of 5.5 percent during the forecast period. Cognitive and memory enhancer drugs are supplements or medications that promote cognitive functional improvement. These are primarily used to treat patients with schizophrenia, stroke, Alzheimer's disease, attention deficit hyperactivity disorder (ADHD), or geriatric patients. The major factors driving the growth of the cognitive and memory enhancer drug market include an increase in the geriatric population and an increase in the prevalence of memory-related disorders and neurological disorders. 

Browse the full report of "The Global Cognitive and Memory Enhancer Drugs Market Size, Share and Trends Analysis Report, By Product (Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and Others), By Application (Disease Treatment (Developmental Conditions, Neurodegenerative Conditions), Academic Performance, and Athletic Performance), Forecast (2022-2028)" at https://www.omrglobal.com/industry-reports/cognitive-and-memory-enhancer-drugs-market

According to the WHO, more than 46 million people are living with dementia, which is a significant factor influencing the growth of this market. Furthermore, ongoing clinical trials and potential drugs approvals by the US FDA are some of the other factors bolstering the market's growth. For instance, in July 2021, the US FDA approved the drug, aducanumab, first new medication for Alzheimer’s disease in the brand name Aduhelm. The drug is a monthly intravenous infusion intended to slow cognitive decline in people with mild memory and thinking problems. It is the first approved treatment to attack the disease process of Alzheimer’s instead of just addressing dementia symptoms.

Market Coverage

1. The market number available for – 2021-2028
2. Base year- 2021
3. Forecast period- 2022-2028

Segment Covered- 

• By Product
• By ???l???t??n

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cognitive and Memory Enhancer Drugs Market by Segment 

By Product 

• Aricept 
• Exelon
• Namenda
• Razadyne
• Provigil
• Ritalin 
• Adderall and Others

By Application 

• Disease Treatment Education 
• Sports and Others

Global Cognitive and Memory Enhancer Drugs Market by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World